Shares of Helen of Troy Limited (NASDAQ:HELE - Get Free Report) passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $24.98 and traded as high as $28.41. Helen of Troy shares last traded at $27.41, with a volume of 317,130 shares traded.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on HELE. Wall Street Zen raised shares of Helen of Troy from a "hold" rating to a "strong-buy" rating in a research report on Sunday, July 12th. Zacks Research lowered shares of Helen of Troy from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 6th. Canaccord Genuity Group boosted their price target on shares of Helen of Troy from $23.00 to $25.00 and gave the stock a "hold" rating in a research report on Thursday, July 9th. Weiss Ratings downgraded shares of Helen of Troy from a "sell (d)" rating to a "sell (d-)" rating in a research note on Tuesday, July 21st. Finally, UBS Group raised their price objective on Helen of Troy from $25.00 to $28.00 and gave the company a "neutral" rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, three have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Helen of Troy has an average rating of "Hold" and an average target price of $26.50.
View Our Latest Analysis on HELE
Helen of Troy Trading Down 2.6%
The company has a market cap of $638.38 million, a price-to-earnings ratio of -1.52 and a beta of 1.31. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.81 and a current ratio of 1.78. The firm has a fifty day moving average price of $28.45 and a 200 day moving average price of $24.98.
Helen of Troy (NASDAQ:HELE - Get Free Report) last issued its earnings results on Wednesday, July 8th. The company reported $0.17 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.15. The business had revenue of $402.12 million for the quarter, compared to the consensus estimate of $374.55 million. Helen of Troy had a negative net margin of 22.70% and a positive return on equity of 6.46%. The firm's revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.41 earnings per share. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. As a group, equities analysts predict that Helen of Troy Limited will post 2.84 EPS for the current fiscal year.
Hedge Funds Weigh In On Helen of Troy
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Paradigm Capital Management Inc. NY raised its stake in Helen of Troy by 64.3% in the first quarter. Paradigm Capital Management Inc. NY now owns 927,100 shares of the company's stock valued at $13,369,000 after buying an additional 362,900 shares during the period. Hsbc Holdings PLC acquired a new position in shares of Helen of Troy during the 1st quarter worth approximately $1,936,000. Renaissance Technologies LLC acquired a new position in shares of Helen of Troy during the 1st quarter worth approximately $571,000. Bank of New York Mellon Corp acquired a new position in shares of Helen of Troy during the 2nd quarter worth approximately $2,768,000. Finally, Wellington Management Group LLP raised its stake in Helen of Troy by 12.8% in the 2nd quarter. Wellington Management Group LLP now owns 824,238 shares of the company's stock valued at $23,961,000 after acquiring an additional 93,350 shares during the period.
About Helen of Troy
(
Get Free Report)
Helen of Troy Limited NASDAQ: HELE is a consumer products company that develops, manufactures, and markets branded products in the beauty, wellness, household, and outdoor categories. Its portfolio includes personal-care and beauty products, health and wellness devices, kitchen and household products, and hydration and outdoor recreation gear.
The company's well-known brands include OXO, Hydro Flask, Osprey, Drybar, Vicks, Braun, Hot Tools, Revlon, and Honeywell-branded products sold under license, among others.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Helen of Troy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helen of Troy wasn't on the list.
While Helen of Troy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.